Some noteworthy, newly updated products of the Congressional Research Service that are not readily available in the public domain include the following (all pdf).
“Congressional Oversight Manual,” updated January 3, 2007.
“Paperwork Reduction Act Reauthorization and Government Information Management Issues,” updated January 4, 2007.
“Nuclear Arms Control: The Strategic Offensive Reductions Treaty,” updated January 3, 2007.
“Proliferation Control Regimes: Background and Status,” updated December 26, 2006.
Nuclear weapons budgeting is like agreeing to buying a house without knowing the sales price, the mortgage rate, or the monthly payment.
Employing a living approach to evidence synthesis, disseminated at a national level, is a streamlined way to enable evidence-based decision-making nationwide.
By providing essential funding mechanisms, the Bioeconomy Finance Program will reduce the risks inherent in biotechnology innovation, encouraging more private sector investment.
While the U.S. has made significant advancements and remained a global leader in biotechnology over the past decade, the next four years will be critical in determining whether it can sustain that leadership.